GALT

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Galectin Therapeutics Inc

NASDAQ | GALT

6.11

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 12, 2025)

$368.18M

Market Cap

-

P/E Ratio

-0.61

EPS

$6.66

52 Week High

$0.72

52 Week Low

HEALTHCARE

Sector

GALT Chart

Recent Chart
Price Action

GALT Technicals

Tags:

GALT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$37K
Total Revenue $0
Cost Of Revenue $37K
Costof Goods And Services Sold $37K
Operating Income -$42M
Selling General And Administrative $5.9M
Research And Development $37M
Operating Expenses $42M
Investment Income Net -
Net Interest Income -$5.2M
Interest Income $338K
Interest Expense $5.5M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $37K
Income Before Tax -$47M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$47M
Comprehensive Income Net Of Tax -
Ebit -$42M
Ebitda -$41M
Net Income -$47M

Revenue & Profitability

GALT Financials

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$37K
Total Revenue $0
Cost Of Revenue $37K
Costof Goods And Services Sold $37K
Operating Income -$42M
Selling General And Administrative $5.9M
Research And Development $37M
Operating Expenses $42M
Investment Income Net -
Net Interest Income -$5.2M
Interest Income $338K
Interest Expense $5.5M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $37K
Income Before Tax -$47M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$47M
Comprehensive Income Net Of Tax -
Ebit -$42M
Ebitda -$41M
Net Income -$47M

GALT News

GALT Profile

Galectin Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Galectin Therapeutics Inc. (GALT) is a clinical-stage biopharmaceutical company based in Norcross, Georgia, that is pioneering the development of innovative therapies aimed at treating fibrotic diseases, certain cancers, and other severe medical conditions. Leveraging its proprietary technology centered on galectin proteins, the company is strategically positioned to target critical pathways in disease progression and inflammation, addressing serious unmet medical needs. With a promising pipeline and a commitment to advancing its therapeutic candidates towards FDA approval, GALT aspires to significantly improve treatment options for patients facing some of the most challenging health issues today.

LPTX
+368.57%
$2.05
PAVS
+21.15%
$0.04
YCBD
+102.85%
$1.28
YGMZ
-61.42%
$0.02
NVDA
-2.13%
$177.07
CGC
+41.58%
$1.59
OCG
+116.24%
$1.97
WOK
-28.86%
$0.11
RIVN
+16.21%
$19.09
KIND
+9.48%
$2.77
AXDX
-61.36%
$0.03
ATPC
-25.44%
$0.13
PLUG
+1.69%
$2.40
TSLA
+0.84%
$450.67
TLRY
+35.47%
$11.42
KAVL
-16.35%
$0.16
AVGO
-10.83%
$362.33
TNYA
-33.66%
$0.90
FRMI
-32.49%
$10.29
ADAP
-15.14%
$0.05
ASST
-2.40%
$0.89
ZDGE
+30.45%
$3.17
AKAN
+19.31%
$0.93
SOND
-23.45%
$0.12
ONDS
+0.56%
$9.07
VIVK
+0.40%
$0.07
INTC
-2.61%
$38.47
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
SRM
+53.27%
$10.30
TE
-9.62%
$5.30
PLTD
+1.90%
$6.44
WULF
-6.79%
$14.75
DNN
-5.80%
$2.59
APLT
-44.12%
$0.12
IRBT
-10.63%
$4.46
BMNR
-5.75%
$36.17
MTSR
-0.35%
$70.50
RR
-8.65%
$4.27
ASBP
-7.84%
$0.09
MARA
-2.01%
$11.60
FI
+2.38%
$68.16
NFLX
+1.34%
$95.35
PLTR
-2.75%
$182.37
F
+1.02%
$13.76
VALE
-4.55%
$12.68
AFMD
-34.94%
$0.18
CRWV
-8.46%
$79.97
RKLB
+0.29%
$63.72
BITF
-5.95%
$2.76
CLSK
-2.64%
$14.42
IVP
-6.59%
$0.04
AMD
-3.52%
$213.63
RZLT
+11.07%
$1.55
AAL
+0.70%
$15.06
TWOH
0.00%
$0.00
GOOGL
-0.85%
$309.75
HOOD
-2.10%
$120.78
GRYP
-10.38%
$1.38
SNAP
-1.89%
$7.49
CAN
-6.61%
$0.86
BBD
+1.31%
$3.45
MODV
-25.22%
$0.43
KPLT
+20.87%
$7.50
CIFR
-6.54%
$17.64
SOUN
-0.46%
$11.97
AMZN
-1.66%
$226.45
NIO
0.00%
$5.13
BTG
-1.82%
$4.59
WBD
+1.30%
$29.87
QBTS
-5.71%
$26.38
PFE
+0.66%
$25.97
HL
-3.85%
$18.60
ABEV
+1.40%
$2.53
ACHR
-3.79%
$8.23
NXDR
-9.11%
$2.51
RIG
-1.75%
$4.20
AG
-6.39%
$15.73
IBRX
+11.41%
$2.44
MU
-4.88%
$245.82
BAC
+1.07%
$55.14
CDE
-2.64%
$17.01
BYND
-3.34%
$1.14
RGTI
-6.54%
$25.12
AAPL
+0.19%
$278.57
SHOT
-74.37%
$0.39
LULU
+10.12%
$205.93
APLD
-6.47%
$28.76
ZAPP
-46.30%
$0.15
BTBT
-7.47%
$2.27
BLNK
-9.93%
$0.79
T
+1.50%
$24.66
PCG
+3.10%
$15.29
CRCG
-13.05%
$2.93
ORCL
-3.57%
$191.74
GPUS
-4.61%
$0.27
ASTS
-7.92%
$78.03
EOSE
-8.85%
$14.98
SPR
+0.22%
$39.50
LPTX
+368.57%
$2.05
PAVS
+21.15%
$0.04
YCBD
+102.85%
$1.28
YGMZ
-61.42%
$0.02
NVDA
-2.13%
$177.07
CGC
+41.58%
$1.59
OCG
+116.24%
$1.97
WOK
-28.86%
$0.11
RIVN
+16.21%
$19.09
KIND
+9.48%
$2.77
AXDX
-61.36%
$0.03
ATPC
-25.44%
$0.13
PLUG
+1.69%
$2.40
TSLA
+0.84%
$450.67
TLRY
+35.47%
$11.42
KAVL
-16.35%
$0.16
AVGO
-10.83%
$362.33
TNYA
-33.66%
$0.90
FRMI
-32.49%
$10.29
ADAP
-15.14%
$0.05
ASST
-2.40%
$0.89
ZDGE
+30.45%
$3.17
AKAN
+19.31%
$0.93
SOND
-23.45%
$0.12
ONDS
+0.56%
$9.07
VIVK
+0.40%
$0.07
INTC
-2.61%
$38.47
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
SRM
+53.27%
$10.30
TE
-9.62%
$5.30
PLTD
+1.90%
$6.44
WULF
-6.79%
$14.75
DNN
-5.80%
$2.59
APLT
-44.12%
$0.12
IRBT
-10.63%
$4.46
BMNR
-5.75%
$36.17
MTSR
-0.35%
$70.50
RR
-8.65%
$4.27
ASBP
-7.84%
$0.09
MARA
-2.01%
$11.60
FI
+2.38%
$68.16
NFLX
+1.34%
$95.35
PLTR
-2.75%
$182.37
F
+1.02%
$13.76
VALE
-4.55%
$12.68
AFMD
-34.94%
$0.18
CRWV
-8.46%
$79.97
RKLB
+0.29%
$63.72
BITF
-5.95%
$2.76
CLSK
-2.64%
$14.42
IVP
-6.59%
$0.04
AMD
-3.52%
$213.63
RZLT
+11.07%
$1.55
AAL
+0.70%
$15.06
TWOH
0.00%
$0.00
GOOGL
-0.85%
$309.75
HOOD
-2.10%
$120.78
GRYP
-10.38%
$1.38
SNAP
-1.89%
$7.49
CAN
-6.61%
$0.86
BBD
+1.31%
$3.45
MODV
-25.22%
$0.43
KPLT
+20.87%
$7.50
CIFR
-6.54%
$17.64
SOUN
-0.46%
$11.97
AMZN
-1.66%
$226.45
NIO
0.00%
$5.13
BTG
-1.82%
$4.59
WBD
+1.30%
$29.87
QBTS
-5.71%
$26.38
PFE
+0.66%
$25.97
HL
-3.85%
$18.60
ABEV
+1.40%
$2.53
ACHR
-3.79%
$8.23
NXDR
-9.11%
$2.51
RIG
-1.75%
$4.20
AG
-6.39%
$15.73
IBRX
+11.41%
$2.44
MU
-4.88%
$245.82
BAC
+1.07%
$55.14
CDE
-2.64%
$17.01
BYND
-3.34%
$1.14
RGTI
-6.54%
$25.12
AAPL
+0.19%
$278.57
SHOT
-74.37%
$0.39
LULU
+10.12%
$205.93
APLD
-6.47%
$28.76
ZAPP
-46.30%
$0.15
BTBT
-7.47%
$2.27
BLNK
-9.93%
$0.79
T
+1.50%
$24.66
PCG
+3.10%
$15.29
CRCG
-13.05%
$2.93
ORCL
-3.57%
$191.74
GPUS
-4.61%
$0.27
ASTS
-7.92%
$78.03
EOSE
-8.85%
$14.98
SPR
+0.22%
$39.50
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.